EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Public ClinicalTrials.gov record NCT02942160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-Label Extension Study of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy
Study identification
- NCT ID
- NCT02942160
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Enrollment
- 259 participants
Conditions and interventions
Conditions
Interventions
- Collagenase Clostridium Histolyticum Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 4, 2016
- Primary completion
- Jun 13, 2018
- Completion
- Jun 13, 2018
- Last update posted
- Nov 23, 2020
2016 – 2018
United States locations
- U.S. sites
- 15
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endo Clinical Trial Site #1 | Beverly Hills | California | 90210 | — |
| Endo Clinical Trial Site #2 | Murrieta | California | 92562 | — |
| Endo Clinical Trial Site #3 | Oceanside | California | 92056 | — |
| Endo Clinical Trial Site #4 | San Diego | California | 92121 | — |
| Endo Clinical Trial Site #5 | Clearwater | Florida | 33756 | — |
| Endo Clinical Trial Site #6 | Coral Gables | Florida | 33146 | — |
| Endo Clinical Trial Site #7 | Palm Beach | Florida | 33401 | — |
| Endo Clinical Trial Site #8 | Washington | Missouri | 63091 | — |
| Endo Clinical Trial Site #10 | New York | New York | 10065 | — |
| Endo Clinical Trial Site #9 | New York | New York | 10075 | — |
| Endo Clinical Trial Site #11 | Nashville | Tennessee | 37215 | — |
| Endo Clinical Trial Site #12 | Pflugerville | Texas | 78660 | — |
| Endo Clinical Trial Site #13 | Charlottesville | Virginia | 22911 | — |
| Endo Clinical Trial Site #14 | Lynchburg | Virginia | 24501 | — |
| Endo Clinical Trial Site #15 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02942160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 23, 2020 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02942160 live on ClinicalTrials.gov.